BPC-157 has an anti-inflammatory profile and in combination may mitigate dermatological side effects
PMID 4154814
For others, especially those living with obesity, insulin resistance, PMOS (formerly PCOS), or prediabetes, medications may become an important part of a personalized treatment plan
The Willow X post doesnt mention that the companys compounded GLP-1 injections and GLP-1 drops, which purportedly contain the same active ingredients in several FDA-approved GLP-1 drugs, specifically, semaglutide and tirzepatide, have not themselves been approved by the FDA
To address this question, we reconstructed the metabolic models previously generated to include GSH succination
23 Specifically, glutathione, perhaps the bodys most potent endogenous antioxidant, is reduced in Hashimotos